Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Nation

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|October 23, 2019
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill PatientsRajbharan Yadav, Phillip J Bergen, Kate E Rogers, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 2014
Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignanciesSiow-Chin Heng, Sharon C-A Chen, C Orla Morrissey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimensAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2010
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide productionJennifer H Moffatt, Marina Harper, Paul Harrison, et al.
Innate Immunity|July 27, 2013
Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniaeTony Velkov, Zakuan Z Deris, Johnny X Huang, et al.
ACS Infectious Diseases|September 15, 2016
A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding EpitopesTony Velkov, Bo Yun, Elena K Schneider, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in AustraliaVanessa E Rees, Deanna S Deveson Lucas, Carla López-Causapé, et al.
Innate Immunity|September 26, 2012
Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid ATony Velkov, Rachel L Soon, Pei L Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancerDishan H Gunawardana, Russell L Basser, Ian D Davis, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|October 23, 2019
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill PatientsRajbharan Yadav, Phillip J Bergen, Kate E Rogers, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 2014
Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignanciesSiow-Chin Heng, Sharon C-A Chen, C Orla Morrissey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimensAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2010
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide productionJennifer H Moffatt, Marina Harper, Paul Harrison, et al.
Innate Immunity|July 27, 2013
Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniaeTony Velkov, Zakuan Z Deris, Johnny X Huang, et al.
ACS Infectious Diseases|September 15, 2016
A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding EpitopesTony Velkov, Bo Yun, Elena K Schneider, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in AustraliaVanessa E Rees, Deanna S Deveson Lucas, Carla López-Causapé, et al.
Innate Immunity|September 26, 2012
Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid ATony Velkov, Rachel L Soon, Pei L Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancerDishan H Gunawardana, Russell L Basser, Ian D Davis, et al.
Pageof 25